August 1, 2025

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring an 82% Potential Upside in the Medical Device Sector

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a dynamic player in the healthcare sector, has been on the radar of many investors, particularly those interested in the medical device industry. Based..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Unveiling a 51.52% Potential Upside Amidst Revenue Challenges

Organogenesis Holdings Inc. (NASDAQ: ORGO) is a key player in the regenerative medicine sector, focusing on advanced wound care and surgical products. As the healthcare industry evolves, Organogenesis stands out..

Cross Country Healthcare, Inc. (CCRN)

⚠️ No article content returned.

..

Mind Medicine (MindMed) Inc. (MNMD) Stock Analysis: A 169% Potential Upside Awaits Investors

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) is capturing the attention of investors with its impressive potential upside of 169.53%, as indicated by recent analyst ratings. As a clinical-stage biopharmaceutical company,..

Abivax SA (ABVX) Stock Report: A 32.54% Upside Potential in the Biotech Arena

Investors with a keen eye on the biotechnology sector would do well to consider Abivax SA (ABVX), a rapidly evolving company at the forefront of developing therapeutics for chronic inflammatory..

Valneva SE (VALN) Stock Analysis: Unpacking the 83.90% Potential Upside in the Biotech Sector

Valneva SE (VALN), a French biotechnology company specializing in the development and commercialization of vaccines, offers a compelling opportunity for investors willing to navigate the high-risk, high-reward terrain of the..

AngioDynamics, Inc. (ANGO) Stock Analysis: Exploring a 105.98% Potential Upside Amidst Steady Revenue Growth

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector with a specialization in medical instruments and supplies, is making waves with its remarkable growth potential. Despite current challenges,..

Upstream Bio, Inc. (UPB) Investor Outlook: A Potential 224% Upside in Biotech

As investors continue to seek opportunities within the dynamic biotechnology sector, Upstream Bio, Inc. (UPB) emerges as a noteworthy contender, particularly for those eyeing companies with substantial growth potential. Headquartered..

Investor Outlook: AxoGen, Inc. (AXGN) Shows Promising Upside with 85.53% Potential Gain

AxoGen, Inc. (NASDAQ: AXGN), a key player in the healthcare sector specializing in medical devices, is capturing attention with its innovative solutions for peripheral nerve regeneration. Headquartered in Alachua, Florida,..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring 91% Potential Upside in the Diagnostics Sector

For investors keen on the healthcare sector, particularly in diagnostics and research, Myriad Genetics, Inc. (NASDAQ: MYGN) presents an intriguing opportunity. As a company that offers a robust portfolio of..

Relay Therapeutics, Inc. (RLAY) Investor Outlook: Unveiling a 311.93% Potential Upside

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage precision medicines company, is making waves in the biotechnology industry with its innovative approach to drug discovery. Based in Cambridge, Massachusetts, Relay Therapeutics..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: A 60% Upside Potential in the Biotech Sector

Arbutus Biopharma Corporation (NASDAQ: ABUS), a clinical-stage biopharmaceutical company, has caught the attention of investors with its promising pipeline and significant upside potential. Specializing in the development of novel therapeutics..

Celcuity Inc. (CELC) Stock Analysis: Biotechnology Innovator with a 55% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a pioneering force in the biotechnology sector, is captivating investors with its focus on developing targeted therapies for solid tumors. Headquartered in Minneapolis, Minnesota, this clinical-stage..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 259% Potential Upside in Genetic Medicine

In the fast-evolving world of genetic medicine, MeiraGTx Holdings plc (NASDAQ: MGTX) stands out as a promising player, offering innovative treatments for serious diseases. This biotech company, focused on developing..

Xeris Biopharma Holdings (XERS) Stock Analysis: A Biotech Player with Strong Revenue Growth and 23.77% Upside Potential

Xeris Biopharma Holdings, Inc. (NASDAQ: XERS), a healthcare sector company specializing in biotechnology, is making waves in the biopharmaceutical industry by developing and commercializing innovative therapies for chronic endocrine and..

Bicara Therapeutics Inc. (BCAX) Stock Analysis: Unveiling a 193% Potential Upside in Biotech

Bicara Therapeutics Inc. (NASDAQ: BCAX), a clinical-stage biopharmaceutical company, is gaining attention in the biotechnology sector with its innovative approach to cancer treatment. Based in Boston, Massachusetts, Bicara is focused..

Fortrea Holdings Inc. (FTRE) Stock Analysis: Navigating the Biotech Terrain with a 16% Potential Upside

Fortrea Holdings Inc. (FTRE) is making waves in the biotechnology sector, currently presenting investors with a tantalizing potential upside of 16.01%. As a U.S.-based contract research organization, Fortrea provides comprehensive..

Tilray Brands, Inc. (TLRY) Stock Analysis: Navigating a 61.63% Potential Upside Amidst Market Challenges

In the dynamic world of cannabis and consumer products, Tilray Brands, Inc. (NASDAQ: TLRY) stands as a notable player. With its diverse portfolio and international reach, Tilray is well-positioned in..

AnaptysBio, Inc. (ANAB) Stock Analysis: Unveiling a 99.59% Potential Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, AnaptysBio, Inc. (NASDAQ: ANAB) presents an intriguing opportunity. With its focus on developing cutting-edge immunology therapeutics, AnaptysBio stands out in..

Opthea Limited (OPT): Investor Outlook Amidst High-Risk, High-Reward Potential in Biotech

Opthea Limited (NASDAQ: OPT), a clinical-stage biopharmaceutical company, is generating buzz in the biotech industry with its innovative approach to combating eye diseases. Headquartered in Melbourne, Australia, this company operates..

Search

Funds

August 1, 2025

Search

Funds

August 1, 2025

FTSE 100

Funds